The immunoblots showed that compared with NC-AD, SELENOW-AD successfully expressed the SELENOW protein at a high and steady level, and had a significant reduction in the levels of the 4-repeat tau isoform, while we did not observe any significant change in the levels of total tau and the 3-repeat tau isoform (Fig. 7b). Here, MAPT is linked to Alzheimer disease.